Concepedia

Rabindranath Tripathy

RT

Statistics

Publications

16

Citations

721

H-Index

15

Active since

1988

Affiliations

Avalon Pharma (United States)(Current)

Brandywine Photonics (United States)

Rabindranath Tripathy is an author at Avalon Pharma (United States) specializing in medicinal chemistry, pharmacology, and drug discovery.

Publications per year

1988–2011

16

Publications

16

Structure-guided identification of novel VEGFR-2 kinase inhibitors via solution phase parallel synthesis

Rabindranath Tripathy, Alyssa Reiboldt, Patricia A. Messina et al. · Bioorganic & Medicinal Chemistry Letters · 2006 · 105 citations · Full text

, , +16

Diels-Alder reaction of dienes having stereogenic allylic substituents: control of diastereoface selectivity by the dienophile

Rabindranath Tripathy, R. W. FRANCK, Kay D. Onan · Journal of the American Chemical Society · 1988 · 98 citations

, , +7

1,2,3-Thiadiazole substituted pyrazolones as potent KDR/VEGFR-2 kinase inhibitors

Rabindranath Tripathy, Arup K. Ghose, Edward R. Bacon et al. · Bioorganic & Medicinal Chemistry Letters · 2006 · 91 citations · Full text

, , +11

Effect of allylic substituents on the face selectivity of Diels-Alder reactions of semicyclic dienes

S. C. Datta, R. W. FRANCK, Rabindranath Tripathy et al. · Journal of the American Chemical Society · 1990 · 50 citations

, , +9

Discovery of a Potent Inhibitor of Anaplastic Lymphoma Kinase with in Vivo Antitumor Activity

Gregory R. Ott, Rabindranath Tripathy, Mangeng Cheng et al. · ACS Medicinal Chemistry Letters · 2010 · 49 citations · Full text

, , +15

1–5 of 16